Skip to content

Opening book details…

About this Medicine article

Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia by Ghia, Paolo (author);Dlugosz-Danecka, Monika (author);Scarfò, Lydia (author);Jurczak, Wojciech (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Ghia, Paolo (author);Dlugosz-Danecka, Monika (author);Scarfò, Lydia (author);Jurczak, Wojciech (author)
Publisher
Informa UK Limited
Published
2021
Field
Medicine (Health Sciences)

More by Ghia, Paolo (author);Dlugosz-Danecka, Monika (author);Scarfò, Lydia (author);Jurczak, Wojciech (author)

Browse all works by Ghia, Paolo (author);Dlugosz-Danecka, Monika (author);Scarfò, Lydia (author);Jurczak, Wojciech (author)